Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement

Immunity
N ThiéblemontS D Wright

Abstract

Lipopolysaccharide ([LPS], an endotoxin) from most bacterial species provokes a strong inflammatory response in naive animals. LPS from Rhodobacter sphaeroides (RsLPS) has a relatively small hydrophobic region and does not stimulate cells or animals but instead acts as antagonist of LPS action. Here, we show that the activity of RsLPS is transformed from antagonist to full agonist by the addition of chlorpromazine (CPZ) and other cationic membrane-active agents. In addition, while LPS is rapidly transported from the plasma membrane to an intracellular site, we find that RsLPS is not transported but instead remains in the cell periphery. Addition of CPZ also reverses this behavior, causing RsLPS to be transported to a perinuclear site. The data suggest that the interaction of LPS with membrane lipids is influenced by membrane-modifying agents such as CPZ, and these interactions dictate both its intracellular transport and its ability to stimulate cellular responses.

References

Jul 1, 1992·Immunology Today·W A Lynn, D T Golenbock
Jun 1, 1986·Chemistry and Physics of Lipids·P R CullisC P Tilcock
Nov 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·M P Sheetz, S J Singer
Dec 1, 1995·The Journal of Experimental Medicine·T KusunokiS D Wright
Jan 1, 1994·The Journal of Experimental Medicine·E HailmanS D Wright
Sep 1, 1994·Immunity·J PuginR J Ulevitch
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·R L DeludeD T Golenbock
Apr 7, 1995·Science·W J ChristM A Mullarkey
Feb 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E T RietschelF Di Padova
Jan 15, 1996·The Journal of Clinical Investigation·J E SomervilleR P Darveau
Feb 23, 1996·The Journal of Biological Chemistry·B Yu, S D Wright
Jan 15, 1997·The Journal of Clinical Investigation·B YuS D Wright
Mar 13, 1997·Nature·B de Kruijff
Mar 1, 1997·Trends in Pharmacological Sciences·F F MoebiusH Glossmann
Jun 5, 1997·Nature·K Simons, E Ikonen
Jun 16, 1997·The Journal of Experimental Medicine·N Thiéblemont, S D Wright

❮ Previous
Next ❯

Citations

Nov 18, 2000·Biochimica Et Biophysica Acta·R DziarskiD Gupta
May 26, 1999·Infectious Disease Clinics of North America·R R IngallsD Golenbock
Sep 25, 2002·Microbes and Infection·Clett ErridgeIan R Poxton
Mar 23, 2000·European Journal of Biochemistry·A B SchrommU Seydel
Dec 8, 1998·The Journal of Experimental Medicine·C J KirschningM Rothe
Feb 17, 1999·The Journal of Experimental Medicine·S D Wright
Aug 17, 1999·The Journal of Experimental Medicine·T VasselonP A Detmers
Aug 17, 1999·The Journal of Experimental Medicine·N Thieblemont, S D Wright
Mar 6, 2002·The Journal of Experimental Medicine·Mathias W HornefAgneta Richter-Dahlfors
Oct 22, 2003·The Journal of Experimental Medicine·Mathias W HornefStaffan Normark
Jul 28, 2013·Science·Nobuhiko KayagakiVishva M Dixit
Sep 24, 1999·Biological Chemistry·A WieseS Müller-Loennies
Jan 12, 2010·The Journal of Chemical Physics·Chester A Faunce, Henrich H Paradies
Feb 20, 2008·The Journal of Chemical Physics·Chester A Faunce, Henrich H Paradies
Mar 17, 2011·The Journal of Chemical Physics·Chester A FaunceHenrich H Paradies
Sep 25, 2007·The Journal of Chemical Physics·Chester A FaunceHenrich H Paradies
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·C A ByrdA Ding
Jan 12, 2010·Current Opinion in Immunology·Anne F McGettrick, Luke A J O'Neill
Sep 24, 2004·Immunology·Eva M Pålsson-McDermott, Luke A J O'Neill
Dec 9, 2004·Immunology Letters·Matilde Leon-PonteJoaquín Madrenas
Oct 30, 2001·International Journal of Medical Microbiology : IJMM·C J Kirschning, S Bauer
Aug 20, 2014·Communicative & Integrative Biology·Vicky Sender, Cordula Stamme
May 1, 2002·Journal of Endotoxin Research·Clett ErridgeIan R Poxton
Apr 29, 2005·Journal of Leukocyte Biology·Adrian A MaungJames A Lederer
Nov 24, 1999·The Journal of Biological Chemistry·R L KitchensR S Munford
Jul 13, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·A BaritussioD Bruttomesso
Feb 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael Heinzelmann, Herbert Bosshart
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R BlunckU Seydel
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D J PhilpottP J Sansonetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here